Innovations in API Manufacturing of Small Molecule Drugs

Innovations in API Manufacturing of Small Molecule Drugs

Whitepapers

How can the pharmaceutical industry improve efficiency, sustainability, and adaptability in API manufacturing?

In this whitepaper, Dirk-Jan van Zoelen, PhD, explores how applying the 6M framework—Manpower, Method, Machine, Material, Measurement, and Mother Nature—enables scientific and operational innovation across the development and scale-up of small molecule APIs.

Learn how emerging technologies like AI, flow chemistry, enzymatic catalysis, and greener synthesis approaches are helping reduce costs and environmental impact—while ensuring quality and regulatory robustness.

Fill in the form to access the full whitepaper.

 

 

Interested in reading the full resource?

Please fill out the form to unlock the rest of the content.

Latest Resources

Our team members share deep, scientific understanding and insights into their respective fields of expertise.

Want to hear more from Ardena?

Sign up to receive drug development insights, the latest on industry trends & Ardena news.

Stay up to date with our latest news and announcements.
Get deep, scientific understanding and insights into our key fields of expertise.
See the events we're attending and register for webinars we're hosting.